| | 206873-63-4 Basic information More.. |
| Product Name: | Tariquidar | | Synonyms: | N-[2-[[[4-[2-(3,4-Dihydro-6,7-diMethoxy-isoquinolin-2(1H)-yl)ethyl]phenyl]aMino]carbonyl]-4,5-diMethoxyphenyl]-3-quinolinecarboxaMide;N-[2-({4-[2-(6,7-diMethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]phenyl}carbaMoyl)-4,5-diMethoxyphenyl]quinoline-3-carboxaMide;N-[2-[[4-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide Tariquidar;Tariquidar
N-[2-[[4-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide;Tariquidar, >=98%;XL9576 Free base;N-[2-[[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxy-phenyl]quinoline-3-carboxamide;Tariquidar | | CAS: | 206873-63-4 | | MF: | C38H38N4O6 | | MW: | 646.73 | | EINECS: | | | Mol File: | 206873-63-4.mol |  |
Use
Tariquidar is a p-glycoprotein drug efflux pump inhibitor. Tariquidar inhibits the ATPase activity of P-glycoprotein, suggesting that the modulating effect is derived from the inhibition of substrate
binding, inhibition of ATP hydrolysis or both.Tariquidar can be considered an ideal agent for testing the role of P-glycoprotein inhibition in cancer
- Tariquidar
-
- US $0.00-0.00 / KG
- 2022-10-14
- CAS:206873-63-4
- Min. Order: 1KG
- Purity: 98%
- Supply Ability: 1Ton
- Tariquidar
-
- US $15.00-10.00 / KG
- 2021-07-13
- CAS:206873-63-4
- Min. Order: 1KG
- Purity: 99%+ HPLC
- Supply Ability: Monthly supply of 1 ton
- Tariquidar
-
- US $15.00-10.00 / KG
- 2021-07-10
- CAS:206873-63-4
- Min. Order: 1KG
- Purity: 99%+ HPLC
- Supply Ability: Monthly supply of 1 ton
|
|
206873-63-4
Recommend Suppliers |
|